Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 40

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Aging alters the cell cycle control and mitogenic signaling responses of human hematopoietic stem cells

Hammond, Colin A., Wu, Si Wei, Wang, Fangwu, MacAldaz, Margarita E., Eaves, Connie J.·2023·Blood
DOI 10.1182/blood.2022017174
Open this paper in CoChat — free account

Abstract

Human hematopoietic stem cells (HSCs), like their counterparts in mice, comprise a functionally and molecularly heterogeneous population of cells throughout life that collectively maintain required outputs of mature blood cells under homeostatic conditions. In both species, an early developmental change in the HSC population involves a postnatal switch from a state in which most of these cells exist in a rapidly cycling state and maintain a high self-renewal potential to a state in which the majority of cells are in a quiescent state with an overall reduced self-renewal potential. However, despite the well-established growth factor dependence of HSC proliferation, whether and how this mechanism of HSC regulation might be affected by aging has remained poorly understood. To address this knowledge gap, we isolated highly HSC-enriched CD34+CD38−CD45RA−CD90+CD49f+ (CD49f+) cells from cord blood, adult bone marrow, and mobilized peripheral blood samples obtained from normal humans spanning 7 decades of age and then measured their functional and molecular responses to growth factor stimulation in vitro and their regenerative activity in vivo in mice that had undergone transplantation. Initial experiments revealed that advancing donor age was accompanied by a significant and progressively delayed proliferative response but not the altered mature cell outputs seen in normal older individuals. Importantly, subsequent dose-response analyses revealed an age-associated reduction in the growth factor–stimulated proliferation of CD49f+ cells mediated by reduced activation of AKT and altered cell cycle entry and progression. These findings identify a new intrinsic, pervasive, and progressive aging-related alteration in the biological and signaling mechanisms required to drive the proliferation of very primitive, normal human hematopoietic cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.2022017174

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1
Figure 1 CC-BY-NC-ND · From the PDF
Figure 2 Similar in vivo repopulating activity of neonatal and adult CD49f + cells when cotransplanted with CD34 + CB ' helper ' cells. (A) Design of a cotransplantation strategy to compare the regenerative potential of CD49f + cells isolated from donors of different ages. (B) Flow-cytometric analysis of the cells in a representative BM aspirate obtained from a mouse that had undergone cotransplantation 12 weeks earlier with CB CD49f + cells and GFP-labeled CD34 + CB cells. (C-D) Percentage of human CD49f + cell (GFP -) (C), and NM, B-lymphoid, erythroid, and CD34 + progeny (D) from input CB, young adult BM, or aged adult BM measured in the total number of viable cells present in the BM aspirate obtained at each time point assessed. Values indicate the geometric mean of pooled values from all mice in each group assessed in 2 independent
Figure 2 Similar in vivo repopulating activity of neonatal and adult CD49f + cells when cotransplanted with CD34 + CB ' helper ' cells. (A) Design of a cotransplantation strategy to compare the regenerative potential of CD49f + cells isolated from donors of different ages. (B) Flow-cytometric analysis of the cells in a representative BM aspirate obtained from a mouse that had undergone cotransplantation 12 weeks earlier with CB CD49f + cells and GFP-labeled CD34 + CB cells. (C-D) Percentage of human CD49f + cell (GFP -) (C), and NM, B-lymphoid, erythroid, and CD34 + progeny (D) from input CB, young adult BM, or aged adult BM measured in the total number of viable cells present in the BM aspirate obtained at each time point assessed. Values indicate the geometric mean of pooled values from all mice in each group assessed in 2 independentCC-BY-NC-ND · From the PDF
Figure 3 GF-stimulated CD49f + cells display a progressive age-related delay in vitro . (A) Design of the culture system used to compare the survival and cell division kinetics of CD49f + cells isolated from differently aged donors over 7 days of culture. (B) Kaplan-Meier curves of CD49f + cell survival in the cultures described in panel A (log-rank test, *** P < .001). (C) Weighted dose-response curves describing the completion of a fi rst division of the different sources of CD49f + tested. Curves re fl ect only CD49f + cells that remained viable past a fi rst division, or until the end of the assay without dividing. Error bars are indicated at the median point of each curve (CB = 57 hours, young adult = 75 hours, aged adult = 90 hours) and indicate the range de fi ned by ± 1 SEM of this estimate (*** P < .001). Time required for clones to complete a second (D) or third (E) division after completing their previous division (*** P < .001).
Figure 3 GF-stimulated CD49f + cells display a progressive age-related delay in vitro . (A) Design of the culture system used to compare the survival and cell division kinetics of CD49f + cells isolated from differently aged donors over 7 days of culture. (B) Kaplan-Meier curves of CD49f + cell survival in the cultures described in panel A (log-rank test, *** P < .001). (C) Weighted dose-response curves describing the completion of a fi rst division of the different sources of CD49f + tested. Curves re fl ect only CD49f + cells that remained viable past a fi rst division, or until the end of the assay without dividing. Error bars are indicated at the median point of each curve (CB = 57 hours, young adult = 75 hours, aged adult = 90 hours) and indicate the range de fi ned by ± 1 SEM of this estimate (*** P < .001). Time required for clones to complete a second (D) or third (E) division after completing their previous division (*** P < .001).CC-BY-NC-ND · From the PDF
Figure 4 Paired cell cycle state and molecular analysis of individually tracked primitive human hematopoietic cells reveal an age-associated prolongation of G1 in the adult cells. (A) Experimental design to enable the in vitro serial immuno fl uorescence tracking of changes in the properties of individual cells isolated from donors of different ages over time. (B) Representative fl uorescence images obtained from the experimental design described in panel A; scale bar = 100 μ m. (C) UMAP distribution of different phenotypic properties of individually assessed CD49f + and CD34 + CD38 -cells from CB and young or aged adult BM cultured for 0, 24, 42, 50, or 64 hours and analyzed as described in panel A. Assignment of regions of the UMAP distribution to the different phases of the cell cycle by K-means clustering (bottom-right). (D) Proportion of CD49f +
Figure 4 Paired cell cycle state and molecular analysis of individually tracked primitive human hematopoietic cells reveal an age-associated prolongation of G1 in the adult cells. (A) Experimental design to enable the in vitro serial immuno fl uorescence tracking of changes in the properties of individual cells isolated from donors of different ages over time. (B) Representative fl uorescence images obtained from the experimental design described in panel A; scale bar = 100 μ m. (C) UMAP distribution of different phenotypic properties of individually assessed CD49f + and CD34 + CD38 -cells from CB and young or aged adult BM cultured for 0, 24, 42, 50, or 64 hours and analyzed as described in panel A. Assignment of regions of the UMAP distribution to the different phases of the cell cycle by K-means clustering (bottom-right). (D) Proportion of CD49f +CC-BY-NC-ND · From the PDF
Figure 5 CD49f + cells show an aging-related increase in their 3GF concentration requirement to stimulate their division. (A) Weighted 3GF dose-response curves for CD49f + cell survival (top) and proliferation (bottom) monitored over a 7-day period in vitro as described in Figure 3A. Proliferation curves are normalized to cells that survived either past a fi rst division or for 7 days without dividing. Points indicate the mean ± 1 SEM of the survival and proliferation responses of each group of cell types assessed (* P < .05; *** P < .001). The 50% effective dose concentrations were interpolated from the fi tted curves (survival: CB = 0.11%, young adult = 0.09%, aged adult = 0.19%; proliferation: CB = 0.2%, young adult = 0.6%, aged adult = 0.9%). (B) Percent of clones that completed the indicated number of divisions by day 7 at 100% 3GF (left) or 1% 3GF (right). Lines connect the observed mean ± 1 SEM of the proportion of cells from each donor source that had completed the indicated number of divisions within 7 days. (*** P < .001; pairwise Kruskal-Wallis tests). (C) Kinetics of 3GF-stimulated timing of a fi rst division of CD49f + cells from different sources exposed to 100% (solid lines) or 1%
Figure 5 CD49f + cells show an aging-related increase in their 3GF concentration requirement to stimulate their division. (A) Weighted 3GF dose-response curves for CD49f + cell survival (top) and proliferation (bottom) monitored over a 7-day period in vitro as described in Figure 3A. Proliferation curves are normalized to cells that survived either past a fi rst division or for 7 days without dividing. Points indicate the mean ± 1 SEM of the survival and proliferation responses of each group of cell types assessed (* P < .05; *** P < .001). The 50% effective dose concentrations were interpolated from the fi tted curves (survival: CB = 0.11%, young adult = 0.09%, aged adult = 0.19%; proliferation: CB = 0.2%, young adult = 0.6%, aged adult = 0.9%). (B) Percent of clones that completed the indicated number of divisions by day 7 at 100% 3GF (left) or 1% 3GF (right). Lines connect the observed mean ± 1 SEM of the proportion of cells from each donor source that had completed the indicated number of divisions within 7 days. (*** P < .001; pairwise Kruskal-Wallis tests). (C) Kinetics of 3GF-stimulated timing of a fi rst division of CD49f + cells from different sources exposed to 100% (solid lines) or 1%CC-BY-NC-ND · From the PDF
Figure 6 AKT signaling drives the 3GF-activated survival and division of primitive human hematopoietic cells. (A) Experimental design used to compare the 3GF-stimulated time course of signaling protein activation assessed by fl ow cytometric analysis. (B) Median relative shift in the intensity of the indicated marker from the corresponding unstimulated sample in CD49f + cells exposed to 3GF for different times. Asterisks indicate signi fi cant differences from the unstimulated samples (* P < .05; ** P < .01; *** P < .001; bootstrapped probabilities). Paired survival (C) and proliferation (D) effects of dimethyl sulfoxide (d)- or triciribine (t)-mediated inhibition of AKT activation. (E) Model of CD49f + pathway activation after short-term 3GF stimulation. The length of the colored bars indicates the relative strength of activation of the indicated marker. CB responses are shown in navy, young adult in red, and aged adult in teal. (F) A model of the role of AKT signaling and other factors in regulating different stages of primitive human hematopoietic cell survival and proliferation.
Figure 6 AKT signaling drives the 3GF-activated survival and division of primitive human hematopoietic cells. (A) Experimental design used to compare the 3GF-stimulated time course of signaling protein activation assessed by fl ow cytometric analysis. (B) Median relative shift in the intensity of the indicated marker from the corresponding unstimulated sample in CD49f + cells exposed to 3GF for different times. Asterisks indicate signi fi cant differences from the unstimulated samples (* P < .05; ** P < .01; *** P < .001; bootstrapped probabilities). Paired survival (C) and proliferation (D) effects of dimethyl sulfoxide (d)- or triciribine (t)-mediated inhibition of AKT activation. (E) Model of CD49f + pathway activation after short-term 3GF stimulation. The length of the colored bars indicates the relative strength of activation of the indicated marker. CB responses are shown in navy, young adult in red, and aged adult in teal. (F) A model of the role of AKT signaling and other factors in regulating different stages of primitive human hematopoietic cell survival and proliferation.CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 48

  1. Laurenti, 2018, From haematopoietic stem cells to complex differentiation landscapes, Nature, 553, 418, 10.1038/nature25022 · DOI
  2. Blanco, 2018, Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood, J Allergy Clin Immunol, 141, 2208, 10.1016/j.jaci.2018.02.017 · DOI
  3. Comans-Bitter, 1997, Immunophenotyping of blood lymphocytes in childhoodReference values for lymphocyte subpopulations, J Pediatr, 130, 388, 10.1016/S0022-3476(97)70200-2 · DOI
  4. Geiger, 2013, The ageing haematopoietic stem cell compartment, Nat Rev Immunol, 13, 376, 10.1038/nri3433 · DOI · Paper page
  5. Guralnik, 2004, Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia, Blood, 104, 2263, 10.1182/blood-2004-05-1812 · DOI · Paper page
  6. Morbach, 2010, Reference values for B cell subpopulations from infancy to adulthood: age-dependent reference values for B cell populations, Clin Exp Immunol, 162, 271, 10.1111/j.1365-2249.2010.04206.x · DOI
  7. Chin, 2022, Aged healthy mice acquire clonal hematopoiesis mutations, Blood, 139, 629, 10.1182/blood.2021014235 · DOI
  8. Mitchell, 2022, Clonal dynamics of haematopoiesis across the human lifespan, Nature, 606, 343, 10.1038/s41586-022-04786-y · DOI · Paper page
  9. Benz, 2012, Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs, Cell Stem Cell, 10, 273, 10.1016/j.stem.2012.02.007 · DOI
  10. Dykstra, 2007, Long-term propagation of distinct hematopoietic differentiation programs in vivo, Cell Stem Cell, 1, 218, 10.1016/j.stem.2007.05.015 · DOI · Paper page
  11. Sanjuan-Pla, 2013, Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy, Nature, 502, 232, 10.1038/nature12495 · DOI
  12. Yamamoto, 2013, Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells, Cell, 154, 1112, 10.1016/j.cell.2013.08.007 · DOI
  13. Amoah, 2022, Aging of human hematopoietic stem cells is linked to changes in Cdc42 activity, Haematologica, 107, 393, 10.3324/haematol.2020.269670 · DOI
  14. Kuranda, 2011, Age-related changes in human hematopoietic stem/progenitor cells: aging of human HSC, Aging Cell, 10, 542, 10.1111/j.1474-9726.2011.00675.x · DOI
  15. Nilsson, 2016, Human and murine hematopoietic stem cell aging is associated with functional impairments and intrinsic megakaryocytic/erythroid bias, PLoS One, 11, e0158369, 10.1371/journal.pone.0158369 · DOI
  16. Belluschi, 2018, Myelo-lymphoid lineage restriction occurs in the human haematopoietic stem cell compartment before lymphoid-primed multipotent progenitors, Nat Commun, 9, 4100, 10.1038/s41467-018-06442-4 · DOI
  17. Huntsman, 2015, Human hematopoietic stem cells from mobilized peripheral blood can be purified based on CD49f integrin expression, Blood, 126, 1631, 10.1182/blood-2015-07-660670 · DOI
  18. Knapp, 2018, Single-cell analysis identifies a CD33 + subset of human cord blood cells with high regenerative potential, Nat Cell Biol, 20, 710, 10.1038/s41556-018-0104-5 · DOI
  19. Knapp, 2017, Dissociation of survival, proliferation, and state control in human hematopoietic stem cells, Stem Cell Reports, 8, 152, 10.1016/j.stemcr.2016.12.003 · DOI
  20. Notta, 2011, Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment, Science, 333, 218, 10.1126/science.1201219 · DOI · Paper page
  21. Wang, 2019, Ultra-high-frequency reprogramming of individual long-term hematopoietic stem cells yields low somatic variant induced pluripotent stem cells, Cell Rep, 26, 2580, 10.1016/j.celrep.2019.02.021 · DOI
  22. Bowie, 2007, Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties, Proc Natl Acad Sci U S A, 104, 5878, 10.1073/pnas.0700460104 · DOI
  23. Foudi, 2009, Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells, Nat Biotechnol, 27, 84, 10.1038/nbt.1517 · DOI · Paper page
  24. Morcos, 2020, Continuous mitotic activity of primitive hematopoietic stem cells in adult mice, J Exp Med, 217, e20191284, 10.1084/jem.20191284 · DOI
  25. Baerlocher, 2007, Longitudinal data on telomere length in leukocytes from newborn baboons support a marked drop in stem cell turnover around 1 year of age, Aging Cell, 6, 121, 10.1111/j.1474-9726.2006.00254.x · DOI
  26. Sidorov, 2009, Leukocyte telomere dynamics and human hematopoietic stem cell kinetics during somatic growth, Exp Hematol, 37, 514, 10.1016/j.exphem.2008.11.009 · DOI · Paper page
  27. Dykstra, 2006, High-resolution video monitoring of hematopoietic stem cells cultured in single-cell arrays identifies new features of self-renewal, Proc Natl Acad Sci U S A, 103, 8185, 10.1073/pnas.0602548103 · DOI
  28. Hui, 2018, High-resolution single-cell DNA methylation measurements reveal epigenetically distinct hematopoietic stem cell subpopulations, Stem Cell Reports, 11, 578, 10.1016/j.stemcr.2018.07.003 · DOI · Paper page
  29. Knapp, 2019, A topological view of human CD34+ cell state trajectories from integrated single-cell output and proteomic data, Blood, 133, 927, 10.1182/blood-2018-10-878025 · DOI
  30. Knapp, 2017, Distinct signaling programs control human hematopoietic stem cell survival and proliferation, Blood, 129, 307, 10.1182/blood-2016-09-740654 · DOI
  31. Miller, 2017, Analysis of parameters that affect human hematopoietic cell outputs in mutant c-kit-immunodeficient mice, Exp Hematol, 48, 41, 10.1016/j.exphem.2016.12.012 · DOI
  32. Loeffler, 2018, Mouse and human HSPC immobilization in liquid culture by CD43- or CD44-antibody coating, Blood, 131, 1425, 10.1182/blood-2017-07-794131 · DOI
  33. Lin, 2015, Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method, Nat Commun, 6, 8390, 10.1038/ncomms9390 · DOI
  34. Copley, 2013, The Lin28b–let-7–Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells, Nat Cell Biol, 15, 916, 10.1038/ncb2783 · DOI
  35. Becht, 2018, Dimensionality reduction for visualizing single-cell data using UMAP, Nat Biotechnol, 37, 38, 10.1038/nbt.4314 · DOI · Paper page
  36. McInnes, 2018, UMAP: Uniform Manifold Approximation and Projection, JOSS, 3, 861, 10.21105/joss.00861 · DOI · Paper page
  37. Laurenti, 2015, CDK6 levels regulate quiescence exit in human hematopoietic stem cells, Cell Stem Cell, 16, 302, 10.1016/j.stem.2015.01.017 · DOI · Paper page
  38. Wilpshaar, 2000, Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34+ cells in NOD/SCID mice, Blood, 96, 2100, 10.1182/blood.V96.6.2100 · DOI
  39. Hume, 2020, A unified model for the G1/S cell cycle transition, Nucleic Acids Res, 48, 12483, 10.1093/nar/gkaa1002 · DOI
  40. Sherr, 2000, The Pezcoller lecture: cancer cell cycles revisited, Cancer Res, 60, 3689
  41. Sherr, 1993, Mammalian G1 cyclins, Cell, 73, 1059, 10.1016/0092-8674(93)90636-5 · DOI
  42. Grover, 2016, Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells, Nat Commun, 7, 11075, 10.1038/ncomms11075 · DOI
  43. Carrelha, 2018, Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells, Nature, 554, 106, 10.1038/nature25455 · DOI
  44. Young, 2021, Decline in IGF1 in the bone marrow microenvironment initiates hematopoietic stem cell aging, Cell Stem Cell, 28, 1473, 10.1016/j.stem.2021.03.017 · DOI · Paper page
  45. García-Gutiérrez, 2019, MYC oncogene contributions to release of cell cycle brakes, Genes (Basel), 10, 244, 10.3390/genes10030244 · DOI
  46. Wang, 2021, Cytokine combinations for human blood stem cell expansion induce cell-type– and cytokine-specific signaling dynamics, Blood, 138, 847, 10.1182/blood.2020008386 · DOI
  47. García-Prat, 2021, TFEB-mediated endolysosomal activity controls human hematopoietic stem cell fate, Cell Stem Cell, 28, 1838, 10.1016/j.stem.2021.07.003 · DOI · Paper page
  48. Loeffler, 2019, Asymmetric lysosome inheritance predicts activation of haematopoietic stem cells, Nature, 573, 426, 10.1038/s41586-019-1531-6 · DOI

Cited by

Metadata

Authors
Hammond, C. A., Wu, S. W., Wang, F., MacAldaz, M. E., & Eaves, C. J.
Affiliations
1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada
Venue
Blood
Publisher
American Society of Hematology
Published
2023-04-20
Volume
141
Issue
16
Pages
1990-2002
ISSN
  • 0006-4971
  • 1528-0020
DOI
10.1182/blood.2022017174
Cited by
40
References
12
Language
en
Licence
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review